A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation
Phase of Trial: Phase I/II
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Islet cell replacement therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Proof of concept
- 07 Jun 2017 Biomarkers information updated
- 22 Dec 2016 According to a Sernova media release, this study is sponsored by JDRF.
- 22 Dec 2016 According to a Sernova media release, update on the company's corporate and business strategy will be presented at the 9th annual Biotech Showcase Conference in San Francisco.